Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 446

1.

Evaluation of a Novel Global Immunity Assay to Predict Infection in Organ Transplant Recipients.

Mian M, Natori Y, Ferreira V, Selzner N, Husain S, Singer L, Kim SJ, Humar A, Kumar D.

Clin Infect Dis. 2017 Dec 21. doi: 10.1093/cid/cix1008. [Epub ahead of print]

PMID:
29281051
2.

A Double Blind Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Adult Solid Organ Transplant Recipients.

Natori Y, Shiotsuka M, Slomovic J, Hoschler K, Ferreira V, Ashton P, Rotstein C, Lilly L, Schiff J, Singer L, Humar A, Kumar D.

Clin Infect Dis. 2017 Dec 14. doi: 10.1093/cid/cix1082. [Epub ahead of print]

PMID:
29253089
3.

Identification of Newly Committed Pancreatic Cells in the Adult Mouse Pancreas.

Socorro M, Criscimanna A, Riva P, Tandon M, Prasadan K, Guo P, Humar A, Husain SZ, Leach SD, Gittes GK, Esni F.

Sci Rep. 2017 Dec 13;7(1):17539. doi: 10.1038/s41598-017-17884-z.

4.

Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.

Baciu C, Pasini E, Angeli M, Schwenger K, Afrin J, Humar A, Fischer S, Patel K, Allard J, Bhat M.

PLoS One. 2017 Dec 7;12(12):e0189223. doi: 10.1371/journal.pone.0189223. eCollection 2017.

5.

Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.

Thomson AW, Humar A, Lakkis FG, Metes DM.

Hum Immunol. 2017 Oct 31. pii: S0198-8859(17)30526-8. doi: 10.1016/j.humimm.2017.10.017. [Epub ahead of print] Review.

PMID:
29100944
6.

Can Viral Load be used as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis.

Natori Y, Alghamdi A, Tazari M, Miller V, Husain S, Komatsu T, Griffiths P, Ljungman P, Orchanian-Cheff A, Kumar D, Humar A; CMV Consensus Forum.

Clin Infect Dis. 2017 Sep 5. doi: 10.1093/cid/cix793. [Epub ahead of print]

PMID:
29020339
7.

Organ utilization from increased infectious risk donors: An observational study.

L'Huillier AG, Humar A, Payne C, Kumar D.

Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12785. Epub 2017 Nov 3.

PMID:
28981193
8.

Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.

Bhimji A, Bhaskaran A, Singer LG, Kumar D, Humar A, Pavan R, Lipton J, Kuruvilla J, Schuh A, Yee K, Minden MD, Schimmer A, Rotstein C, Keshavjee S, Mazzulli T, Husain S.

Clin Microbiol Infect. 2017 Sep 29. pii: S1198-743X(17)30531-1. doi: 10.1016/j.cmi.2017.09.018. [Epub ahead of print]

PMID:
28970160
9.

Effect of organ donation after circulatory determination of death on number of organ transplants from donors with neurologic determination of death.

Rao V, Dhanani S, MacLean J, Payne C, Paltser E, Humar A, Zaltzman J.

CMAJ. 2017 Sep 25;189(38):E1206-E1211. doi: 10.1503/cmaj.161043.

10.

Impact of Immunosuppression on the Metagenomic Composition of the Intestinal Microbiome: a Systems Biology Approach to Post-Transplant Diabetes.

Bhat M, Pasini E, Copeland J, Angeli M, Husain S, Kumar D, Renner E, Teterina A, Allard J, Guttman DS, Humar A.

Sci Rep. 2017 Aug 31;7(1):10277. doi: 10.1038/s41598-017-10471-2.

11.

Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).

Vinayak R, Cruz RJ Jr, Ranganathan S, Mohanka R, Mazariegos G, Soltys K, Bond G, Tadros S, Humar A, Marsh JW, Selby RR, Reyes J, Sun Q, Haberman K, Sindhi R.

Liver Transpl. 2017 Dec;23(12):1577-1588. doi: 10.1002/lt.24847.

12.

Time to Consider Cytomegalovirus Prevention in Critically Ill Patients?

Kumar D, Humar A.

JAMA. 2017 Aug 22;318(8):709-710. doi: 10.1001/jama.2017.10132. No abstract available.

PMID:
28829852
13.

Surgical and medical approach to patients requiring total small bowel resection: Managing the "no gut syndrome".

Cruz RJ Jr, Butera L, Poloyac K, McGurgan J, Stein W, Binion D, Humar A.

Surgery. 2017 Oct;162(4):871-879. doi: 10.1016/j.surg.2017.05.012. Epub 2017 Jul 26.

PMID:
28755968
14.

Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.

Lontos K, Agha M, Raptis A, Hou JZ, Farah R, Redner RL, Im A, Dorritie KA, Sehgal A, Rossetti J, Saul M, Gooding WE, Humar A, Boyiadzis M.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13052. Epub 2017 Aug 9.

PMID:
28710776
15.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW.

Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381.

PMID:
28654545
16.

The Living Donor Collective: A Scientific Registry for Living Donors.

Kasiske BL, Asrani SK, Dew MA, Henderson ML, Henrich C, Humar A, Israni AK, Lentine KL, Matas AJ, Newell KA, LaPointe Rudow D, Massie AB, Snyder JJ, Taler SJ, Trotter JF, Waterman AD; Living Donor Collective participants.

Am J Transplant. 2017 Dec;17(12):3040-3048. doi: 10.1111/ajt.14365. Epub 2017 Jun 22.

PMID:
28520316
17.

Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.

Emond JC, Goodrich NP, Pomposelli JJ, Baker TB, Humar A, Grant DR, Abt P, Friese CE, Fisher RA, Kam I, Sherker AH, Gillespie BW, Merion RM.

Transplantation. 2017 Oct;101(10):2375-2384. doi: 10.1097/TP.0000000000001823.

PMID:
28514251
18.

An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation.

Kumar D, Mian M, Singer L, Humar A.

Am J Transplant. 2017 Sep;17(9):2468-2473. doi: 10.1111/ajt.14347. Epub 2017 Jun 16.

PMID:
28500691
19.

Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU.

PLoS Pathog. 2017 May 10;13(5):e1006386. doi: 10.1371/journal.ppat.1006386. eCollection 2017 May.

20.

Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.

Kumar D, Patil N, Husain S, Chaparro C, Bhat M, Kim SJ, Humar A.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.13000. Epub 2017 Jun 1.

PMID:
28489256

Supplemental Content

Loading ...
Support Center